Details of the Drug

General Information of Drug (ID: DM5NBIR)

• Drug Name: ABT-335
• Synonyms: Choline fenofibrate

Indication

Disease Entry	ICD 11	Status	REF
Dyslipidemia	5C80-5C81	Approved	[1]

• ATC Code:
  C10AB11: ABT-335
  C10AB: Fibrates
  C10A: LIPID MODIFYING AGENTS, PLAIN
  C10: LIPID MODIFYING AGENTS
  C: CARDIOVASCULAR SYSTEM
• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C22H28ClNO5
  Canonical SMILES: CC(C)(C(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl.C[N+](C)(C)CCO
  InChI: InChI=1S/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1
  InChIKey: JWAZHODZSADEHB-UHFFFAOYSA-M
• Cross-matching ID:
  PubChem CID: 11350701
  CAS Number: 856676-23-8
  TTD ID: D01HKL

References

• [1] Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study. Am Heart J. 2009 Jan;157(1):195-203.